Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Cystic Fibrosis
NCT03925194Phase 2Terminated
- Sponsor
- Heidelberg University
- Start
- Dec 2022
- Primary completion
- Jun 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Anakinra with Placebo (2 arms). Primary endpoint: Lung Clearance Index at 28 days. Started Dec 2022; status: terminated.
02
Drugs
anakinra
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03925194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03925194.